Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Children With Newly-Diagnosed Low Stage Lymphocyte Predominant Hodgkin Disease (LPHD)

NCT00107198 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00107198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00107198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Children With Newly-Diagnosed Low Stage Lymphocyte Predominant Hodgkin Disease (LPHD)
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
March 10, 2006
Completion date
March 31, 2026
Enrollment
188 (actual)
Sites
170

Conditions

As the registry lists them; a condition with its own page is linked.

ann arbor stage i childhood hodgkin lymphoma, ann arbor stage ii childhood hodgkin lymphoma, childhood nodular lymphocyte predominant b-cell lymphoma